Berger A - Search Results

1

Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.

Stephan C, Berger A, Carlebach A, Lutz T, Bickel M, Klauke S, Staszewski S, Stuermer M. Stephan C, et al. Among authors: berger a. J Antimicrob Chemother. 2005 Dec;56(6):1087-93. doi: 10.1093/jac/dki396. Epub 2005 Nov 3. J Antimicrob Chemother. 2005. PMID: 16269552

2

Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany.

Weber B, Rabenau H, Berger A, Scheuermann EH, Staszewski S, Kreuz W, Scharrer I, Schoeppe W, Doerr HW. Weber B, et al. Among authors: berger a. Zentralbl Bakteriol. 1995 Jan;282(1):102-12. doi: 10.1016/s0934-8840(11)80802-9. Zentralbl Bakteriol. 1995. PMID: 7734823

3

Rebound of HIV-1 viral load after suppression to very low levels.

Staszewski S, Miller V, Sabin C, Berger A, Hill AM, Phillips AN. Staszewski S, et al. Among authors: berger a. AIDS. 1998 Dec 3;12(17):2360. AIDS. 1998. PMID: 9863886 No abstract available.

4

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A. Staszewski S, et al. Among authors: berger am. AIDS. 1999 Feb 25;13(3):367-73. doi: 10.1097/00002030-199902250-00009. AIDS. 1999. PMID: 10199227

5

Human immunodeficiency virus and hepatitis B virus infection in pregnancy: diagnostic potential of viral genome detection.

Berger A, Doerr HW, Weber B. Berger A, et al. Intervirology. 1998;41(4-5):201-7. doi: 10.1159/000024937. Intervirology. 1998. PMID: 10213897 Review.

6

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.

Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A. Staszewski S, et al. Among authors: berger a. AIDS. 1999 May 28;13(8):951-6. doi: 10.1097/00002030-199905280-00011. AIDS. 1999. PMID: 10371176

7

The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection.

Berger A, Preiser W, Doerr HW. Berger A, et al. J Clin Virol. 2001 Jan;20(1-2):23-30. doi: 10.1016/s1386-6532(00)00151-7. J Clin Virol. 2001. PMID: 11163579 Review.

8

Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV.

Berger A, Preiser W. Berger A, et al. J Antimicrob Chemother. 2002 May;49(5):713-21. doi: 10.1093/jac/dkf050. J Antimicrob Chemother. 2002. PMID: 12003963 Review.

9

Haemolytic anaemia after nucleotide antiretroviral treatment discontinuation in a chronic hepatitis B-virus co-infected AIDS patient.

Stephan C, Brodt HR, Berger A, Lutz T, Mösch M, Lennemann TS, Stürmer M, Staszewski S. Stephan C, et al. Among authors: berger a. AIDS. 2004 Jul 23;18(11):1613-4. doi: 10.1097/01.aids.0000131371.98198.86. AIDS. 2004. PMID: 15238788 No abstract available.

10

HBV reactivation after kidney transplantation.

Berger A, Preiser W, Kachel HG, Stürmer M, Doerr HW. Berger A, et al. J Clin Virol. 2005 Feb;32(2):162-5. doi: 10.1016/j.jcv.2004.10.006. J Clin Virol. 2005. PMID: 15653420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,951 results

Search Page

Filters